about
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objec...
Read More
9.40
-1.12
(-10.65%)
1.2M
XNAS Volume
XNAS 08 Sep, 2025 5:30 PM (EDT)
Board Meeting
The board meeting for Immunome Inc is scheduled for today, for the purpose of Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Immunome Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..